Related Experiment Video
Updated: Dec 6, 2025

Isolation and Characterization of Single Cells from Zebrafish Embryos
Published on: March 12, 2016
Gap junction protein beta 4 plays an important role in cardiac function in humans, rodents, and zebrafish
Ryuji Okamoto1, Itaru Goto1, Yuhei Nishimura2
1Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
Insights
A mutation in the GJB4 gene, encoding connexin 30.3, can cause familial hypertrophic cardiomyopathy (HCM). This finding identifies GJB4 as a potential therapeutic target for heart disease.
Area of Science:
- Cardiovascular Biology
- Genetics
- Molecular Medicine
Background:
- Gap junctions are crucial for cardiac function, formed by connexin proteins.
- GJB4 encodes connexin 30.3 (Cx30.3), a transmembrane protein.
- The role of GJB4 in human heart disease remains largely unexplored.
Observation:
- A novel GJB4 mutation (E204A) was identified in siblings with severe hypertrophic cardiomyopathy (HCM).
- This mutation impaired GJB4's interaction with GJA1 (connexin 43) and altered its expression and localization in cardiac cells.
- GJB4 expression was upregulated in various animal models of cardiac hypertrophy and dysfunction.
Findings:
- GJB4 expression and localization were significantly altered in human diseased hearts and patient-derived cardiomyocytes.
- GJB4 deficiency in zebrafish led to reduced cardiac function, including lower ejection fraction.
- The GJB4-E204A mutation is associated with a familial form of HCM.
Implications:
- GJB4 is identified as a novel connexin implicated in diseased hearts.
- GJB4 mutations represent a potential genetic cause of familial HCM.
- GJB4 may serve as a new therapeutic target for treating cardiac hypertrophy and dysfunction.
Aims:
GJB4 encodes a transmembrane connexin protein (Cx30.3) that is a component of gap junctions. This study investigated whether GJB4 plays an important role in human heart disease and function.
Methods And Results:
We examined a patient and her older brother who both presented with complicated severe hypertrophic cardiomyopathy (HCM) and whose parents are healthy married cousins. The gene exome analysis showed 340 single nucleotide polymorphisms (SNPs) that caused amino acid changes for which the patient was homozygous and both parents were heterozygous. After excluding all known common (>10%) SNP gene mutations, the gene for GJB4 was the only identified gene that is possibly associated with cardiac muscle. The resultant E204A substitution exists in the 4th transmembrane domain. GJB4-E204A impaired the binding with gap junction protein A1 (GJA1) compared with GJB4-WT. The expression of GJB4 was induced in rat disease models of left and right ventricle hypertrophy and mouse disease models of adriamycin-induced cardiomyopathy and myocardial infarction, while it was not detected at all in control. An immunohistochemical study was performed for autopsied human hearts and the explanted heart of the patient. GJB4 was expressed and colocalized with GJA1 in intercalated discs in human diseased hearts, which was extensively enhanced in the explanted heart of the patient. The abnormal expression and localization of GJB4 were observed in beating spheres of patient's induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CMs). We generated knockout zebrafish of GJB4 by CRISPR/Cas9 and the endodiastolic volume and the ventricular ejection fraction were significantly lower in GJB4-deficient than in wild-type zebrafish at five days post-fertilization.
Conclusions:
These results indicate both that GJB4 is defined as a new connexin in diseased hearts, of which mutation can cause a familial form of HCM, and that GJB4 may be a new target for the treatment of cardiac hypertrophy and dysfunction.
Related Concept Videos
Gap Junctions
Gap Junctions
G-Protein Gated Ion Channels
Sensory...
Mechanism of Cardiac Arrhythmias

